MindMaze Therapeutics Holding S.A. Sponsored ADR
MindMaze Therapeutics Holding S.A. Sponsored ADR
- Market cap
- $11.96M
Your view on RLFTY
Overview
What the company does, where it operates, and who runs it.
About MindMaze Therapeutics Holding S.A. Sponsored ADR
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Alexandre Capet
- Headquarters
- Bâtiment F2/F3, Geneva, CH
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Alexandre Capet
- Headquarters
- Bâtiment F2/F3, Geneva, CH
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for MindMaze Therapeutics Holding S.A. Sponsored ADR. Starting points for MindMaze Therapeutics Holding S.A. Sponsored ADR: EPS -$0.99, beta 0.73 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for MindMaze Therapeutics Holding S.A. Sponsored ADR. MindMaze Therapeutics Holding S.A. Sponsored ADR does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for MindMaze Therapeutics Holding S.A. Sponsored ADR. Trailing twelve-month EPS for MindMaze Therapeutics Holding S.A. Sponsored ADR stands at -$0.99. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for MindMaze Therapeutics Holding S.A. Sponsored ADR. MindMaze Therapeutics Holding S.A. Sponsored ADR has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| DTC.CNDefence Therapeutics Inc. | Healthcare | CNQ | $40.5M | ||
| DTCFFDefence Therapeutics Inc. | Healthcare | OTC | $22.9M | ||
| DTILPrecision BioSciences, Inc. | Healthcare | NASDAQ | $206.7M | ||
| DVHGFDevonian Health Group Inc. | Healthcare | OTC | $29.5M | ||
| DWTXDogwood Therapeutics, Inc. | Healthcare | NASDAQ | $39.6M | ||
| DXB.AXDimerix Limited | Healthcare | ASX | — | ||
| DYAIDyadic International, Inc. | Healthcare | NASDAQ | $11.5M | ||
| DYNDyne Therapeutics, Inc. | Healthcare | NASDAQ | $2.9B | ||
| EDITEditas Medicine, Inc. | Healthcare | NASDAQ | $253.1M | ||
| EDSAEdesa Biotech, Inc. | Healthcare | NASDAQ | $19.3M | ||
| EFTReFFECTOR Therapeutics, Inc. | Healthcare | OTC | $941 | ||
| EHOSEhouse Global, Inc. | Healthcare | OTC | $10,127 | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for MindMaze Therapeutics Holding S.A. Sponsored ADR. Coverage tracks MindMaze Therapeutics Holding S.A. Sponsored ADR within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of MindMaze Therapeutics Holding S.A. Sponsored ADR.